News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Efficacy of subsequent therapies in advanced ovarian cancer
baybiosciences.com
Nov 13, 2024, 23:26

Efficacy of subsequent therapies in advanced ovarian cancer

Annals of Oncology shared a post on X:

“New article in press: Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.”

therapies

advanced ovarian cancer Annals of Oncology cancer ENGOT-ov25 trial olaparib OncoDaily Oncology
Special Coverage
Blog
Apr 1, 2025, 07:32
Shravan Nadkarni: Registration is open for the Laparoscopic Colorectal Surgery Live Workshop
Science
Apr 1, 2025, 07:29
Talha Badar: Predictors of CNS relapse in APL
Blog
Apr 1, 2025, 07:24
Jenny Seligmann: World-class discovery science and clinicians collaborating on colorectal trial cohorts
Opinion
Apr 1, 2025, 07:19
Yüksel Ürün: Low-dose CT for lung cancer screening in a high-risk population
Blog
Apr 1, 2025, 07:09
Virginia Galvín: Should critical medications be integrated into defense budgets?
Blog
Apr 1, 2025, 06:51
Kendra Paabo: The 3 worst words you can say to someone with cancer
Blog
Apr 1, 2025, 06:49
Ali Atoui: Honored to Receive the 2025 CHAMP Award from the American Society of Hematology
Drugs
Apr 1, 2025, 06:49
Tislelizumab (Tevimbra): What Patients need to know?
Blog
Apr 1, 2025, 06:34
Trainee Day provided a space for trainees to connect and grow within the EBMT community
Blog
Apr 1, 2025, 06:20
Abhishek Chatterjee: The inaugural Stryker Breast Care Oncoplastic Surgery course has finished
Insight
Apr 1, 2025, 04:51
MD Anderson Cancer Center broke ground on a new 470,000-square-foot facility in Sugar Land
Blog
Apr 1, 2025, 04:49
Katy Beckermann: Secondary Analysis of the TITAN Trial